← Back

Wire · opportunities

Ladera Medical Presents Full FASTEN Results Showing Rapid Hemostasis and a ...

Published

22 November 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

Australia

◆ Source

Read at us.acrofan.com →

◆ Verified

Fusion42 · 22 November 2026 · Fusion42 review

Ladera Medical announced full results from the FASTEN trial showing their Large Bore Closure System achieves rapid hemostasis and a strong safety profile in patients undergoing transfemoral TAVR/TAVI, with a 98.1% freedom from major complications at 30 days and a mean time to hemostasis of 0.5 minutes.

This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it.

◆ ◆ The Wire takeaway

You can now offer a single-device solution for large bore femoral closure that significantly reduces complications and procedure time. This device opens a rare opportunity to capture market share in TAVR vascular closure where current methods still rely on multiple devices or implants.

◆ Coverage

2 sources · 22 Nov 2026

◆ Related on Wire

◆ Topics

Medtechhemostasisvascular-closurecardiovascularclinical-trialmedical-device